Last reviewed · How we verify

NCT04943237

Anti-TNF Therapy and Nerve Conduction Studies in Ankylosing Spondylitis

Completed Last updated 29 June 2021
What this trial tests

trial testing Anti-TNF agents in Anti - TNF Therapy in 60 participants. Completed in 1 October 2019.

Timeline
1 July 2019
Primary endpoint
1 October 2019
1 October 2019

Quick facts

Lead sponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 July 2019
Primary completion1 October 2019
Estimated completion1 October 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Who can join

Adults 20 to 65, any sex, with Anti - TNF Therapy or Ankylosing Spondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with ankylosing spondylitis were divided into 2 groups as anti-TNF and conventional therapy according to the treatments they were using for the last 5 years. Nerve conduction studies in the upper and lower extremities of the patients were compared.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Anti-TNF agents

Trials testing the same drug.

Other Istanbul Physical Medicine Rehabilitation Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04943237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing